Navigation Links
Startup to develop new solid-state technology at UCLA for use in medical imaging
Date:4/2/2010

While today many medical-imaging needs are being met with traditional vacuum tubebased technology, large segments of the X-rayimaging market are poorly served, and there is widespread demand for both performance improvements and cost reductions.

Based on groundbreaking patented technology licensed from UCLA, startup company Radius Health is developing a lightweight, flat-panel X-ray source Microemitter Array X-rays (MAX) technology that has the potential to address these needs by enabling new X-ray imaging applications while lowering the cost of traditional applications.

The startup has been selected to move into the UCLA on-campus incubator space at the California NanoSystems Institute to develop a lightweight X-ray emitter employing MAX technology an X-ray source on a chip capable of delivering the same spectrum as traditional sources.

The MAX technology was developed by Gil Travish, Ph.D., a research scientist in the UCLA Department of Physics and Astronomy, and his colleagues James Rosenzweig, a UCLA professor of physics, and Rodney Yoder, an assistant professor of physics at Manhattanville College in New York.

The MAX technology works like this: Using an array of particle sources from microfabricated structures, parallel X-rays are generated uniformly across a flat panel. The MAX source, which can be produced using the current generation of semiconductor foundry processes, generates diagnostic X-rays without the need for fragile vacuum tubes and bulky, expensive power electronics and radioactive materials.

The technology has the potential to deliver advanced and potentially safer imaging options than are available with current commercial X-ray systems, and to extend the 'application space' of X-ray radiology.

"Moving our development activities into CNSI is a real landmark moment for us," said Mark Evans, CEO for Radius Health. "The access to the facilities and knowledge will greatly he
'/>"/>

Contact: Jennifer Marcus
jmarcus@cnsi.ucla.edu
310-267-4839
University of California - Los Angeles
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Silicon Valley Entrepreneur Launches Startup to Accelerate Tech Entrepreneurship in Upstate New York
2. Informatics experts contribute to special Health Affairs edition on e-health in the developing world
3. Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinsons Disease Biomarker Pipeline
4. Developing a cyberinfrastructure for comparative effectiveness in cancer research
5. Oakland University William Beaumont School of Medicine Reaches Development Milestone
6. Electrical Muscle Stimulation Proven to Enhance Muscle Development and Sports Performance
7. Entest BioMedical Enters into LOI with Advanced Light Devices to Develop Laser Platform for Stem Cell / Laser COPD Treatment
8. New York City Surgeon Develops All-Natural Treatment for Wrinkles and Scars
9. FDA Collaboration Seeks to Speed Development of Pneumococcal Vaccines for Children in Developing Countries
10. University of Alberta researchers develop drug interface to save lives
11. The Colorado Institute for Drug, Device and Diagnostic Development Launches With a Statewide Call for Proposals From Life Science Technologies in Need of Funding and Active Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 2014 The newly updated Worldwide Medical ... thousands of facts, figures and forecasts on the global ... sector forecast categories the Worldwide Medical Market Forecasts ... national views on the worldwide medical market to reveal ... gives you data for 2010-2019, covering each country market ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Allegheny General ... procedure that enables physicians to repair a damaged mitral ... MitraClip system, developed by Abbott Vascular ... a progressive and life-threatening condition in which the heart’s ... to flow backward from the heart’s left ventricle into ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 ASCNYC ... organization that helps New Yorkers living with HIV/AIDS ... toward health, housing, recovery and self-sufficiency. Each year, ... the local community through their tireless efforts. , ... Marc Shapses , has been selected as this ...
(Date:10/20/2014)... October 20, 2014 T.E.N., a ... firm, announced today that William H. Murray, renowned ... 2014 ISE® Luminary Leadership Award winner. Presented annually, ... of an outstanding leader and industry practitioner for ... in advancing the information security industry. , Formerly ...
(Date:10/20/2014)... October 20, 2014 Zereana Jess-Huff, a 34-year-old ... Maryland 2014 on a platform to think outside the bra. ... uses her position to raise awareness about women’s other lady ... breast cancer. You say the color pink and everybody knows ... for a fact that it has not been won when ...
Breaking Medicine News(10 mins):Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3
... Restrictions should be placed on the use of Ginkgo biloba ... growing scientific evidence that Ginkgo may increase the risk of ... of anti-seizure drugs, a new report concludes. The article appears ... also suggests that Ginkgo may have harmful effects in other ...
... polycarbonate plastic source of a huge environmental headache because ... key to disposing of the waste in an eco-friendly way, ... Biomacromolecules , a monthly journal. Mukesh Doble and ... of plastic containing BPA each year. Polycarbonate is an extremely ...
... manufacturers are rolling out a new generation of products ... according to an article in the current issue of ... C&EN Assistant Managing Editor Michael McCoy points out ... fabric cleaning products is occurring despite a rocky economy ...
... trials will begin soon, researchers say , WEDNESDAY, Jan. ... as a treatment for uterine fibroids, say U.S. researchers ... therapy. , Uterine fibroids, which affect 40 percent of ... fatigue and lack of energy. Currently, hysterectomy is the ...
... ... over the world to win the one they want, and ultimately, to win in love. ... Boston, MA (PRWEB) January 27, 2010 -- ... the release of the movie Valentine’s Day, this year even more than ever, there is a ...
... A hair ... by the researchers who demonstrated its potential, because it is still in the early stages ... ... hair restoration surgeons Dr Gary Hitzig and Dr Jerry Cooley created a technique that multiplies ...
Cached Medicine News:Health News:A Different Kind of Valentine's Day Story 2Health News:Hair Cloning Not Yet Recommended by Researchers Who Developed the Technique 2
(Date:10/22/2014)... CAMBRIDGE, Mass. , Oct. 22, 2014 ... Cambridge, MA is revolutionizing spinal cord ... technique has been shown to outperform in tissue regrowth ... with the scaffold.  Made from an FDA approved polymer, ... dioxide; making it harmless to the human body. NVIV ...
(Date:10/22/2014)... and AUSTIN, Texas , Oct. ... LLC today announced they have entered into a ... immunotherapies designed to target cancers. PhosImmune ... displayed on the surfaces of tumor cells in ... (PTTs), derived from proteins that play a role ...
(Date:10/22/2014)... , Oct. 22, 2014  Recently published clinical ... bolstered the already substantial database of evidence. This data ... of Stretta therapy for sufferers of refractory ... clinical evidence supporting Stretta therapy as a safe ... that make Stretta therapy available to nearly 50 million ...
Breaking Medicine Technology:InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets 2Recent Clinical Study Data Confirms Efficacy of Stretta Therapy - Spurs Additional Insurance Coverage and Financing Round 2
... , July 15 /PRNewswire-Asia-FirstCall/ -- China Medical ... China -based advanced in-vitro,diagnostic ("IVD") company, today announced ... used in a research project focusing on cancer targeted ... which is,sponsored by the Chinese Ministry of Health. One ...
... , DALLAS , July 14 After two days ... (FDA) recommended that the FDA allow the type 2 diabetes drug rosiglitazone ... members suggesting that the label be revised to include increased warnings. Rosiglitazone ... treat type 2 diabetes. , , ...
Cached Medicine Technology:China Medical Technologies Announces the Use of its HER-2 FISH Probe in a Cancer Targeted Therapy Research Project Sponsored by the Chinese Ministry of Health 2China Medical Technologies Announces the Use of its HER-2 FISH Probe in a Cancer Targeted Therapy Research Project Sponsored by the Chinese Ministry of Health 3American Heart Association Comment: Advisory Committee Recommends that U.S. Food and Drug Administration Keep Rosiglitazone (Avandia) on the Market, Continue Clinical Trial of Safety and Efficacy 2American Heart Association Comment: Advisory Committee Recommends that U.S. Food and Drug Administration Keep Rosiglitazone (Avandia) on the Market, Continue Clinical Trial of Safety and Efficacy 3American Heart Association Comment: Advisory Committee Recommends that U.S. Food and Drug Administration Keep Rosiglitazone (Avandia) on the Market, Continue Clinical Trial of Safety and Efficacy 4
Digital Thermometer & High-Low Temp Alarm, -50C to +90C...
... The F340 is a basic laboratory ... compensated pH results can be obtained when ... a 3-in-1 electrode. • Fast and easy ... buffer recognition for five buffers (pH 1.68, ...
... laboratory system for pH and temperature measurements. ... when used with a temperature probe (ATC) ... easy one and two-point calibration with Auto-Find ... 1.68, 4.00, 7.00, 10.01 and 12.45) and ...
... microplate reader combines improved flexibility ... with a wide range of ... the flexibility, sensitivity and high ... is the ideal detection solution ...
Medicine Products: